Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Emergent Biosolutions (NY: EBS)
14.56 USD  +0.13 (+0.90%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Emergent Biosolutions
 
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Emergent BioSolutions Provides Preliminary 2009 Financial Results and Guidance for 2010
January 11, 2010
from Business Wire News Releases
HHS Cancels RFP for rPA Procurement and Modifies Their Approach in Favor of BAA for Development of rPA Vaccines
December 07, 2009
from Business Wire News Releases
Former U.K. Health Protection Agency Director Rejoins Emergent BioSolutions to Head Biodefense Business
December 01, 2009
from Business Wire News Releases
Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
November 30, 2009
from Business Wire News Releases
Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore
November 13, 2009
from Business Wire News Releases
Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2009
November 05, 2009
from Business Wire News Releases
Southwest IDEAS Conference Announces Presenting Company Lineup, Lunch Programs
November 04, 2009
from GlobeNewswire News Releases
Standard & Poor's Announces Changes to U.S. Index
November 02, 2009
from PR Newswire
Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
November 02, 2009
from Business Wire News Releases
OXiGENE to Acquire VaxGen in a Stock-for-Stock Merger
October 15, 2009
from GlobeNewswire News Releases
Emergent BioSolutions Sponsors Security and Defence Agenda Roundtable on Biopreparedness
October 14, 2009
from Business Wire News Releases
Emergent BioSolutions to Release Third Quarter 2009 Financial Results and Conduct a Conference Call on November 5, 2009
October 08, 2009
from Business Wire News Releases
Beacon Equity Issues Technical Trading Overview for XOMA Ltd.
October 01, 2009
from GlobeNewswire News Releases
NIAID to Fund Development of Emergent BioSolutions’ Advanced Anthrax Vaccine Candidate
September 30, 2009
from Business Wire News Releases
Emergent BioSolutions Issues Statement on Court Ruling
September 14, 2009
from Business Wire News Releases
Emergent BioSolutions to Webcast Presentation at Upcoming Investor Conference
September 04, 2009
from Business Wire News Releases
The Southwest IDEAS Investor Conference to be Held November 11 and 12, 2009
August 18, 2009
from GlobeNewswire News Releases
Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2009
August 06, 2009
from Business Wire News Releases
Emergent BioSolutions Expands Manufacturing and Development Infrastructure Through a Series of Real Estate Transactions
August 06, 2009
from Business Wire News Releases
Emergent BioSolutions to Release Second Quarter 2009 Financial Results and Conduct a Conference Call on August 6, 2009
July 21, 2009
from Business Wire News Releases
Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Winner in Greater Washington
June 18, 2009
from Business Wire News Releases
Emergent BioSolutions Chief Financial Officer, Don Elsey, Named SmartCFO of the Year
June 15, 2009
from Business Wire News Releases
Emergent BioSolutions Meets With FDA To Review Regulatory Strategy for Recombinant Anthrax Vaccine
June 11, 2009
from Business Wire News Releases
Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Years
June 10, 2009
from Business Wire News Releases
Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
May 26, 2009
from Business Wire News Releases
Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday, May 21, 2009 at 10:00 am Eastern
May 19, 2009
from Business Wire News Releases
Emergent BioSolutions Submits to FDA Development Plan Required of Bidders in Competitive Range for Recombinant Anthrax Vaccine (rPA) Contract with HHS
May 13, 2009
from Business Wire News Releases
AnalystChoice.com Free Investment Opinion on CZZ, EBS, HME and HRP
May 11, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC). Read More
from Marketwired News Releases
Emergent BioSolutions Launches BioThrax.com, an Educational Website about BioThrax (Anthrax Vaccine Adsorbed) and Anthrax Disease
May 08, 2009
from Business Wire News Releases
Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Finalist in Greater Washington
May 08, 2009
from Business Wire News Releases
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here